DNA Phenotyping and RNA Profiling in Forensic Science

Classical STR profiling, covered in the DNA structure, extraction and profiling techniquesbullet, is a comparison method. You run the crime-scene profile against a suspect or a database (CODIS, or the Indian National DNA Database under the DNA Technology Bill framework). No match, no answer.

Forensic DNA phenotyping fills the gap on the front end. From the same swab, FDP returns a probabilistic description of the unknown donor: most likely eye colour, hair colour, skin colour, biogeographic ancestry, and, with methylation assays, approximate age. None of this identifies the person; it narrows the suspect pool the way an eyewitness description would, but from the biology itself.

RNA profiling fills a parallel gap on the sample side. STR profiling tells you whose cells are on the swab; it does not tell you whether those cells came from blood, saliva, semen, vaginal epithelium or menstrual blood. That distinction often decides the charge, and the classical presumptive tests have known specificity problems. mRNA and miRNA panels read the transcript signature of the fluid directly.

The exam framing is straightforward: FDP and RNA profiling areinvestigative aidsnot standalone identification evidence.

FDP rests on the observation that a small number of well-chosen SNPs explain most of the heritable variation in a few visible traits. The panels and their targets:

Points the MCQs lean on: HIrisPlex-S is the integrated panel because it combines eye, hairandskin colour in one assay (41 SNPs); the "S" is the skin extension. Biogeographic ancestry uses Ancestry-Informative Markers (AIMs), SNPs whose allele frequencies differ between continental populations. Age estimation does not use SNPs at all; it uses DNA methylation at CpG sites whose level changes predictably with age, the so-called epigenetic clock.

Indian-population angle: most published FDP panels were trained on European, East Asian and African reference samples. The Centre for DNA Fingerprinting and Diagnostics (CDFD, Hyderabad) has begun population-frequency work on Indian samples, but the validation gap is real and underlies most admissibility objections.

The end-to-end FDP workflow moves from DNA extraction through targeted SNP library preparation, NGS sequencing, and prediction software. Representative tools at each stage:

Two facts to lock in:MiSeq FGx is the dedicated forensic NGS sequencer(Illumina MiSeq chemistry, validated for ForenSeq), and Parabon Snapshot is a commercial FDP service not an open-source pipeline. The Snapshot composite is a probabilistic prediction, not a photograph.

For NGS context, the MiSeq / Ion S5 instruments belong to the same high-throughput, dedicated-software toolkit you meet in the hyphenated instrumental techniquesbullet for chemical evidence.

The classical body-fluids workflowrelies on colour-change presumptive tests (Kastle-Meyer, acid phosphatase, amylase) followed by confirmatory tests (Takayama, p30/PSA, microscopy). The colour tests are sensitive but not specific. RNA profiling answers the body-fluid question by reading the transcripts that are highly expressed only in that fluid.

mRNA markers(tissue-specific, co-extracted with DNA):

• Blood: HBA, HBB, ALAS2, CD93.
• Saliva: STATH (statherin), HTN3 (histatin), MUC7.
• Semen: PRM1, PRM2 (protamines), TGM4, KLK3.
• Vaginal secretion: MUC4, HBD1, LCN1.
• Menstrual blood: MMP7, MMP10, MMP11 (matrix metalloproteinases).

miRNA markers are much shorter (~22 nt) and considerably more stable in degraded samples than mRNA. Standard markers include miR-451 / miR-144 for blood, miR-205 for saliva, miR-891a for semen and miR-412 for menstrual blood. miRNA is the class that survives best in aged or degraded stains.

Advantages over classical serology: higher specificity, the ability to identify menstrual blood specifically (classical tests cannot separate menstrual from peripheral blood), and parallel processing on the same extract. Limitations: RNA lability, RT chemistry cost, and the absence of routine accredited deployment in Indian labs so far.

FDP predicts traits the analyst cannot observe directly and generates group-level ancestry inferences that can map onto categories with a history of misuse. The principal concerns are:

1. Probabilistic, not deterministic. FDP returns a probability ("brown eyes, 87%"). Presenting a single colour as fact overstates the science.
2. Biogeographic ancestry sensitivity. Continental ancestry can be confused for racial or caste categorisation; group-based suspect-pool framing is a real risk in a multi-ethnic country.
3. Trait creep. The same SNP architecture could extend to behavioural or medical predictions. German and Dutch FDP laws explicitly cap the permitted traits.
4. Population-database adequacy. Most FDP algorithms are under-trained on South Asian samples, weakening accuracy for Indian donors.

For Indian admissibility, the operative statute is the Bharatiya Sakshya Adhiniyam 2023Section 39 of which governs expert opinion. The BSA does not specifically address FDP, and Indian courts have so far treated FDP outputs as investigative leads, not substantive identification evidence. The DNA Technology (Use and Application) Regulation Bill restricts permitted uses of DNA data to identification, missing persons, parentage and disaster-victim ID; phenotype prediction is not an enumerated purpose. CDFD and DFSS have flagged the need for an explicit regulatory frame before FDP enters routine casework.